No question in medicines information punishes oversimplification like pregnancy. "Is it safe?" has no honest one-word answer, because the real answer depends on gestational stage, dose and duration, the maternal indication and the risks of leaving it untreated, the route, the alternatives available, and the strength of an evidence base that is, for structural reasons, almost never trial-grade. The UK stack for this question is genuinely good, better than most clinicians realise, and the skill is knowing which source carries which piece. Here is the map, and how to run the conversation from it.
The resource stack
The exact product’s SmPC section 4.6 provides the authorised wording on fertility, pregnancy and lactation. UKTIS provides professional evidence synthesis about exposure in pregnancy, while BUMPS translates that evidence for patients. SPS, NICE, obstetric and specialty guidance support clinical interpretation and implementation. iatroX Medicines can orient users to the relevant sources; it does not replace patient-specific risk assessment or specialist advice.
Patient-facing versus professional information
Respect the audience and purpose of each source. Clinicians can use UKTIS and applicable specialist guidance to interpret the evidence, check the exact SmPC for the authorised product position, and share an appropriate BUMPS leaflet with the patient. The conversation should include the risks of both treatment and untreated illness, the limits of the evidence, and the reason for the recommendation.
Why the SmPC often sounds more cautious
A pattern worth pre-explaining to patients who will read the leaflet anyway: authorised product wording is bound to the evidence submitted for the licence, and pregnant women are systematically excluded from trials, so the regulatory text frequently defaults to caution that specialist assessment of accumulated real-world evidence has since superseded. When the SmPC and UKTIS diverge in tone, both are doing their jobs; the professional synthesis is the clinician's, documented.
Worked examples
Amoxicillin: the commonest shape of the question, a first-line antibiotic with reassuring accumulated experience, where the page's linked NHS and pregnancy sources support a short, confident conversation, and the indication itself does most of the deciding. Nitrofurantoin: the stage-dependent shape, where gestational timing, renal function, the indication and product-specific warnings interact, and the answer at one point in pregnancy is not the answer at another; the clinical page's framing plus UKTIS carries it. Apixaban: the specialist-review shape, anticoagulation in pregnancy is a pathway decision about alternatives, not a leaflet decision, and the stack's job is to route fast to the specialist layer. Paracetamol: the self-care shape, a common question deserving context about indication and sensible use rather than a bare yes, with the patient-facing sources doing the explaining.
Frequently asked questions
Is BUMPS reliable?
Yes: its leaflets are based on scientific material prepared by UKTIS, incorporating the published evidence, which makes it the rare patient-facing source with a professional evidence engine underneath.
What is the difference between BUMPS and UKTIS?
Audience and depth: same evidence base, with UKTIS serving professionals, and its information feeding national bodies, and BUMPS translating it for patients.
What should be documented after the conversation?
The exposure or proposed treatment, the sources consulted, the risks discussed in both directions, treated and untreated, the decision and its rationale, and the follow-up plan. The documentation is the shared decision made durable.
Where do breastfeeding questions fit?
Same stack, adjacent sources: the SmPC's 4.6, SPS's breastfeeding guidance, and the specialist services; the pregnancy discipline, evidence over labels, transfers wholesale.
Should medicines be stopped pre-emptively when pregnancy is confirmed?
Not reflexively: abrupt discontinuation of necessary treatment is itself a risk, and the correct move is prompt review, with the stack above, of each medicine's evidence against the risks of the untreated condition. "Stop everything" is the error the professional layer exists to prevent, in both directions.
Who do professionals contact for complex cases?
UKTIS's professional service for teratology questions, the relevant specialist team for pathway decisions, and pharmacy for the practical residue; the routing matters more than heroic solo synthesis.